Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study

Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study

Abstract Background The current study evaluated the long-term (52 week) safety and impact on symptom measures of lurasidone (with or without lithium or valproate) for the treatment of bipolar I disorder in Japanese patients. Methods Bipolar patients for this open-label flexibly dosed lurasidone (20–...

Full description

Bibliographic Details
Main Authors: Teruhiko Higuchi, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Jun Ishigooka
Format: Article
Language:English
Published: SpringerOpen 2021-08-01
Series:International Journal of Bipolar Disorders
Subjects:
Lurasidone
Bipolar disorder
Atypical antipsychotic
Online Access:https://doi.org/10.1186/s40345-021-00230-8

Internet

https://doi.org/10.1186/s40345-021-00230-8

Similar Items